CRISPR Therapeutics is a biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases. By utilizing its proprietary CRISPR/Cas9 platform, the company aims to create a new class of medicines that have the potential to treat, or even cure, complex diseases by correcting underlying genetic defects.
With a diverse pipeline covering hemoglobinopathies, oncology, regenerative medicine, and rare diseases, CRISPR Therapeutics is at the forefront of the genetic medicine revolution. The company emphasizes a collaborative approach to scientific discovery, partnering with industry leaders like Vertex Pharmaceuticals to scale its efforts and bring groundbreaking therapies from the laboratory to patients in need.